Neoadjuvant paclitaxel (P), carboplatin (Ca) and gemcitabine (G) in patients with locally advanced transitional cell carcinoma (TCC) of the bladder: A final report.

被引：0
|
作者：
Smith, D. C.
Mackler, N. J.
Hussain, M. H.
Dunn, R.
Montie, J. E.
Wood, D.
Lee, C. T.
Petrylak, D.
Quinn, D.
Vaishampayan, U.
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Columbia Presbyterian Med Ctr, New York, NY USA
[3] Univ So Calif, Los Angeles, CA USA
[4] Wayne State Univ, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：226S / 226S
页数：1
相关论文
共 50 条
  • [41] Adjuvant Chemotherapy With Gemcitabine Plus Cisplatin for Kidney Transplant Patients With Locally Advanced Transitional Cell Carcinoma
    Wang, Z. P.
    Wang, W. Y.
    Zhu, Y. C.
    Xiao, J.
    Lin, J.
    Guo, Y. W.
    Tian, Y.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (06) : 2076 - 2079
  • [42] Cisplatin Versus Carboplatin and Paclitaxel in Radiochemotherapy for Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
    Nassif, Sandy
    Wichmann, Jorn
    Strube, Dominic
    Vassis, Stratos
    Christiansen, Hans
    Steinmann, Diana
    IN VIVO, 2022, 36 (02): : 821 - 832
  • [43] Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study
    Li Jiang
    Jie Zhu
    Xue Chen
    Yi Wang
    Lei Wu
    Gang Wan
    Yongtao Han
    Xuefeng Leng
    Lin Peng
    Qifeng Wang
    Radiation Oncology, 17
  • [44] Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study
    Jiang, Li
    Zhu, Jie
    Chen, Xue
    Wang, Yi
    Wu, Lei
    Wan, Gang
    Han, Yongtao
    Leng, Xuefeng
    Peng, Lin
    Wang, Qifeng
    RADIATION ONCOLOGY, 2022, 17 (01)
  • [45] MULTIMODAL TREATMENT OF LOCALLY ADVANCED TRANSITIONAL-CELL BLADDER-CARCINOMA IN ELDERLY PATIENTS
    VERONESI, A
    LORE, G
    CARBONE, A
    TROVO, MG
    DALBO, V
    TALAMINI, R
    SANTAROSSA, S
    FRANCINI, M
    MONFARDINI, S
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (07) : 918 - 920
  • [46] Phase III trial of induction gemcitabine (G) or paclitaxel (T) plus carboplatin (C) followed by elective T consolidation in advanced ovarian cancer (OC): Final safety and efficacy report.
    Teneriello, M. G.
    Gordon, A. N.
    Lim, P.
    Janicek, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18)
  • [47] Gemcitabine, carboplatin and paclitaxel as neoadjuvant combination chemotherapy in patients with locally advanced (stage III) or inflammatory breast cancer - a non-anthracycline alternative
    Kambye, C.
    Nielsen, D. L.
    Baislev, E.
    EJC SUPPLEMENTS, 2010, 8 (03): : 193 - 193
  • [48] Long-term survival after gemcitabine and cisplatin in patients with locally advanced transitional cell carcinoma of the bladder: Focus on supplementary treatment strategies
    Als, Anne Birgitte
    Sengelov, Lisa
    von der Maase, Hans
    EUROPEAN UROLOGY, 2007, 52 (02) : 478 - 487
  • [49] Correlation of clinical outcome with p53 and p21 status in patients with advanced transitional-cell carcinoma treated with paclitaxel and carboplatin
    Flamm, M
    Brodowicz, T
    Haitel, A
    Susani, M
    Tomek, S
    Köstler, W
    Pycha, A
    Kratzik, C
    Marberger, M
    Zielinski, CC
    ANTICANCER RESEARCH, 2002, 22 (2B) : 1295 - 1300
  • [50] Trastuzumab (Herceptin®) in patients with HER-2-overexpressing metastatic or locally advanced transitional cell carcinoma of the bladder:: report on 7 patients
    Salzberg, Marc
    Borner, Markus
    Bauer, Jean-Alexandre
    Morant, Rudolf
    Rauch, Daniel
    Rochlitz, Christoph
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (15) : 2660 - 2661
12345